Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates
* Recalculate survival curves for each P L C and O trial outcomes to compare cancer mortality versus late-stage stage cancer incidence
* Estimate survival curves by screening results and covariates to examine interactions of arm by screening result and covariates
Ping Hu (NCI)
Paul Pinsky (NCI)
-
Data-integration with pseudoweights and survey-calibration: application to developing US-representative lung cancer risk models for use in screening.
Wang L, Li Y, Graubard BI, Katki HA
J R Stat Soc Ser A Stat Soc. 2025 Jan; Volume 188 (Issue 1): Pages 119-139 PUBMED